The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Chip-scale implantable bionics for next generation therapeutic neural prostheses. Australia has an unmatched reputation as a world leader in neuroprostheses. Most notable of these is the bionic ear and, more recently, leading edge research towards a bionic eye. This project will combine the research strengths and experiences from both the hearing and visual bionics fields to address the main obstacles that prevent the number of electrical stimulation channels (equating to the number of frequenci ....Chip-scale implantable bionics for next generation therapeutic neural prostheses. Australia has an unmatched reputation as a world leader in neuroprostheses. Most notable of these is the bionic ear and, more recently, leading edge research towards a bionic eye. This project will combine the research strengths and experiences from both the hearing and visual bionics fields to address the main obstacles that prevent the number of electrical stimulation channels (equating to the number of frequencies heard by the deaf, and the number of spots of light seen by the blind) from increasing. The study will improve our understanding of the electrode-tissue interface, the life-long implantablity, and electrical circuitry that will allow future bionic devices to significantly improve their performance.Read moreRead less